Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study-Reference-Cited by-同舟云学术

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

Published:2013-01-12 Issue:1 Volume:73 Page:183-190
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Wallace Daniel J,Kalunian Kenneth,Petri Michelle A,Strand Vibeke,Houssiau Frederic A,Pike Marilyn,Kilgallen Brian,Bongardt Sabine,Barry Anna,Kelley Lexy,Gordon Caroline

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference32 articles.

1. Systemic lupus erythematosus;D'Cruz;Lancet,2007

2. Systemic lupus erythematosus;Tsokos;N Engl J Med,2011

3. Understanding the epidemiology and progression of systemic lupus erythematosus;Pons-Estel;Semin Arthritis Rheum,2010

4. Why can't we find a new treatment for SLE?;Eisenberg;J Autoimmun,2009

5. New and emerging treatment approaches to lupus;Haubitz;Biologics,2010

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical markers, metrics, indices, and clinical trials;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Biologics in Systemic Lupus Erythematosus: Recent Evolutions and Benefits;Pharmaceutics;2024-09-06

3. Disease activity assessment in systemic lupus erythematosus;Frontiers in Lupus;2024-08-21

4. New and emerging therapies for systemic lupus erythematosus;Clinical Immunology;2024-06

5. Lupus eritematoso sistémico;EMC - Aparato Locomotor;2024-06